Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells

被引：35

作者：

de Frias, Merce ^{[1
]}

Iglesias-Serret, Daniel ^{[1
]}

Cosialls, Ana M. ^{[1
]}

Coll-Mulet, Llorenc ^{[1
]}

Santidrian, Antonio F. ^{[1
]}

Gonzalez-Girones, Diana M. ^{[1
]}

de la Banda, Esmeralda ^{[2
]}

Pons, Gabriel ^{[1
]}

Gill, Joan ^{[1
]}

机构：

[1] Univ Barcelona, IDIBELL, Dept Ciencies Fisiol 2, Lhospitalet De Llobregat, Spain

[2] Bellvitge Hosp, IDIBELL, Serv Hematol, Lhospitalet De Llobregat, Spain

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 12期

关键词：

Akt; chronic lymphocytic leukemia; apoptosis; PROTEIN-KINASE-C; FORKHEAD TRANSCRIPTION FACTOR; GLYCOGEN-SYNTHASE KINASE-3; B-CELLS; SIGNALING PATHWAY; ANTIGEN RECEPTOR; IN-VITRO; SURVIVAL; ACTIVATION; EXPRESSION;

D O I：

10.3324/haematol.2008.004028

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background The phosphatidylinositol-3-kinase/Akt pathway has been described to be critical in the survival of chronic lymphocytic leukemia cells. In this study we analyzed the effect of two selective chemical inhibitors of Akt (Akti-1/2 and A-443654) on the survival of chronic lymphocytic leukemia cells. Design and Methods Using cytometry we studied the cytotoxic effects of Akt inhibitors on peripheral B and T lymphocytes from patients with chronic lymphocytic leukemia and from healthy donors. We studied the changes induced by Akti-1/2 and A-443654 at the mRNA level by performing reverse transcriptase multiplex ligation-dependent probe amplification. We also studied the changes induced by both Akt inhibitors in some BCL-2 protein family members on chronic lymphocytic leukemia cells by western blotting. Moreover, we analyzed the cytotoxic effect of Akt inhibitors in patients' cells with deleted/mutated TP53. Results Both inhibitors induced apoptosis in chronic lymphocytic leukemia cells in a dose-dependent manner. Moreover, B cells from patients with chronic lymphocytic leukemia were more sensitive to Akt inhibitors than T cells from leukemic patients, and B or T cells from healthy donors. Survival factors for chronic lymphocytic leukemia cells, such as interleukin-4 and stromal cell-derived factor-1 alpha, were not able to block the apoptosis induced by either Akt inhibitor. Akti-1/2 did not induce any change in the mRNA expression profile of genes involved in apoptosis, while A-443654 induced some changes, including an increase in NOXA and PUMA mRNA levels, suggesting the existence of additional targets for A-443654. Both inhibitors induced an increase in PUMA and NOXA protein levels, and a decrease in MCL-1 protein level. Moreover, Akti-1/2 and A-443654 induced apoptosis irrespective of TP53 status. Conclusions These results demonstrate that Akt inhibitors induce apoptosis of chronic lymphocytic leukemia cells and might be a new therapeutic option for the treatment of chronic lymphocytic leukemia.

引用

页码：1698 / 1707

页数：10

共 40 条

[21] Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition [J].

Han, E. K-H ;

Leverson, J. D. ;

McGonigal, T. ;

Shah, O. J. ;

Woods, K. W. ;

Hunter, T. ;

Giranda, V. L. .

ONCOGENE, 2007, 26 (38) :5655-5661

[22] Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB [J].

Hu, XJ ;

Haney, N ;

Kropp, D ;

Kabore, AF ;

Johnston, JB ;

Gibson, SB .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (10) :9498-9508

[23] Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis [J].

Jones, DT ;

Ganeshaguru, K ;

Anderson, RJ ;

Jackson, TR ;

Bruckdorfer, KR ;

Low, SY ;

Palmqvist, L ;

Prentice, HG ;

Hoffbrand, AV ;

Mehta, AB ;

Wickremasinghe, RG .

BLOOD, 2003, 101 (08) :3174-3180

[24] IMMUNOSUPPRESSION WITH PURINE ANALOGS - THE FLIP SIDE OF THE GOLD COIN [J].

KEATING, MJ .

ANNALS OF ONCOLOGY, 1993, 4 (05) :347-348

[25] Disparate expression of the PTEN gene:: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL) [J].

Leupin, N ;

Cenni, B ;

Novak, U ;

Hügli, B ;

Graber, HU ;

Tobler, A ;

Fey, MF .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (01) :97-100

[26] Characterization of a protein kinase B inhibitor in vitro and in insulin-treated liver cells [J].

Logie, Lisa ;

Ruiz-Alcaraz, Antonio J. ;

Keane, Michael ;

Woods, Yvonne L. ;

Bain, Jennifer ;

Marquez, Rudolfo ;

Alessi, Dario R. ;

Sutherland, Calum .

DIABETES, 2007, 56 (09) :2218-2227

[27] The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease [J].

Longo, P. G. ;

Laurenti, L. ;

Gobessi, S. ;

Petlickovski, A. ;

Pelosi, M. ;

Chiusolo, P. ;

Sica, S. ;

Leone, G. ;

Efremov, D. G. .

LEUKEMIA, 2007, 21 (01) :110-120

[28] The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells [J].

Longo, Pablo G. ;

Laurenti, Luca ;

Gobessi, Stefania ;

Sica, Simona ;

Leone, Giuseppe ;

Efremov, Dimitar G. .

BLOOD, 2008, 111 (02) :846-855

[29] Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo [J].

Luo, Y ;

Shoemaker, AR ;

Liu, XS ;

Woods, KW ;

Thomas, SA ;

de Jong, R ;

Han, EK ;

Li, TM ;

Stoll, VS ;

Powlas, JA ;

Oleksijew, A ;

Mitten, MJ ;

Shi, Y ;

Guan, R ;

McGonigal, TP ;

Klinghofer, V ;

Johnson, EF ;

Leverson, JD ;

Bouska, JJ ;

Mamo, M ;

Smith, RA ;

Gramling-Evans, EE ;

Zinker, BA ;

Mika, AK ;

Nguyen, PT ;

Oltersdorf, T ;

Rosenberg, SH ;

Li, Q ;

Giranda, VL .

MOLECULAR CANCER THERAPEUTICS, 2005, 4 (06) :977-986

[30] Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation [J].

Mackus, WJM ;

Kater, AP ;

Grummels, A ;

Evers, LM ;

Hooijbrink, B ;

Kramer, MHH ;

Castro, JE ;

Kipps, TJ ;

van Lier, RAW ;

van Oers, MHJ ;

Eldering, E .

LEUKEMIA, 2005, 19 (03) :427-434

← 1 2 3 4 →